The result revealed that high level of GLUT3 was closely associated with inferior overall survival of patients with distinct pathologic stages (Fig. 1j–n), while GLUT1 was not associated with prognosis of CRC (Supplementary Fig. S3a–c). This evidence concerns the gene SLC2A1 and colorectal carcinoma.